Hemostemix Announces Positive Results and Conclusions Reported in Phase II CLI Trial Abstract
October 21, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, Oct. 21, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company developing and commercializing...
Cynata Advances Toward Phase 2 Clinical Trial of Cymerus(TM) MSCs in Patients with Osteoarthritis
October 04, 2019 08:05 ET
|
Cynata Therapeutics Limited
MELBOURNE, Australia, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Cynata Therapeutics Limited (ASX: CYP), a clinical-stage biotechnology company specialising in cell therapeutics, is pleased to provide an...
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity.
October 01, 2019 04:33 ET
|
Esperite N.V.
Esperite N.V. (ESP) : Update to the market on its Cord Blood Stem Cells Subsidiaries and activity. Amsterdam, The Netherlands – 1st October 2019 Esperite N.V. (the Group) confirmed on 22nd February...
Live Cell Imaging Market To Reach USD 3.76 Billion By 2026 | Reports And Data
August 27, 2019 12:03 ET
|
Reports and Data
New York, Aug. 27, 2019 (GLOBE NEWSWIRE) -- Factors contributing to the growing CAGR are rising incidences of cancer, diabetes and cardiovascular disorders worldwide, adoption of high-content...
GenCure announces breakthrough first run of 80-liter bioreactor
August 13, 2019 09:10 ET
|
BioBridge Global
San Antonio, Texas, Aug. 13, 2019 (GLOBE NEWSWIRE) -- In a breakthrough for the regenerative medicine industry, GenCure announced today that its biomanufacturing services team has successfully...
Organovo Announces Release Date for Fiscal First-Quarter 2020 Financial Results
July 18, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, July 18, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) will host a conference call on Thursday, August 8, 2019 at 5:00 p.m. Eastern Time (ET) to discuss the...
Hemostemix Announces Ongoing Phase II CLI Trial Abstract Accepted for Presentation by Canadian Society for Vascular Surgery
July 02, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, July 02, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company developing and commercializing...
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE.
July 02, 2019 02:47 ET
|
Esperite N.V.
ESPERITE (N.V) WITH CRYOSAVE ANNOUNCES THE RELEASE OF TWO CORD BLOOD STEM CELLS SAMPLES FOR TREATMENTS AND THEREFORE CONFIRMS THE IMPORTANCE OF STEM CELLS IN THE FIELD OF REGENERATIVE MEDICINE. ...
Hemostemix Announces Enrollment Update for the ACP-01 Phase II Critical Limb Ischemia Clinical Trial
June 27, 2019 08:30 ET
|
Hemostemix Inc.
CALGARY, Alberta, June 27, 2019 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF) is pleased to announce that it has enrolled a total of forty (40)...
Organovo Collaborates With MCRI and Leiden University Medical Center to Develop Stem Cell-Based Bioprinted Tissue Treatments for Kidney Disease
May 30, 2019 08:05 ET
|
Organovo, Inc.
SAN DIEGO, May 30, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range...